PDCD1 and neoplasm: An in vivo study identified higher numbers of the immunosuppressive Arg1+ macrophages in tumors and showed that anti-programmed cell death-1 (anti-PD-1) treatment diminishes Arg1+ and increases Arg1- TAMs in the tumor microenvironment [131].